BioMark Diagnostics Inc. (BUX.CN)

CAD 0.2

(0.0%)

Gross Profit Summary of BioMark Diagnostics Inc.

BioMark Diagnostics Inc.'s latest annual gross profit in 2023 was 163.22 Thousand CAD , up 1.18% from previous year.
BioMark Diagnostics Inc.'s latest quarterly gross profit in 2024 Q1 was -19.44 Thousand CAD , up 68.15% from previous quarter.
BioMark Diagnostics Inc. reported a annual gross profit of -232.7 Thousand CAD in annual gross profit 2022, down -629.68% from previous year.
BioMark Diagnostics Inc. reported a annual gross profit of 43.93 Thousand CAD in annual gross profit 2021, up 421.01% from previous year.
BioMark Diagnostics Inc. reported a quarterly gross profit of -229.95 Thousand CAD for 2023 FY, up 1.18% from previous quarter.
BioMark Diagnostics Inc. reported a quarterly gross profit of -48.38 Thousand CAD for 2023 Q2, up 22.89% from previous quarter.

Annual Gross Profit Chart of BioMark Diagnostics Inc. (2023 - 2013)

Historical Annual Gross Profit of BioMark Diagnostics Inc. (2023 - 2013)

Year	Gross Profit	Gross Profit Growth
2023	163.22 Thousand CAD	1.18%
2022	-232.7 Thousand CAD	-629.68%
2021	43.93 Thousand CAD	421.01%
2020	-13.68 Thousand CAD	-105.2%
2019	263.28 Thousand CAD	0.0%
2018	- CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%
2015	- CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	-19.44 Thousand CAD	68.15%
2023 FY	-229.95 Thousand CAD	1.18%
2023 Q2	-48.38 Thousand CAD	22.89%
2023 Q1	-62.75 Thousand CAD	0.38%
2023 Q3	-57.76 Thousand CAD	-19.37%
2023 Q4	-61.04 Thousand CAD	-5.68%
2022 Q1	35.9 Thousand CAD	48.87%
2022 FY	-232.7 Thousand CAD	-629.68%
2022 Q4	-62.99 Thousand CAD	-270.77%
2022 Q3	36.88 Thousand CAD	166.29%
2022 Q2	-55.64 Thousand CAD	-255.01%
2021 Q2	-2586.00 CAD	0.04%
2021 FY	43.93 Thousand CAD	421.01%
2021 Q4	24.11 Thousand CAD	21.68%
2021 Q3	19.81 Thousand CAD	866.36%
2021 Q1	-2587.00 CAD	61.62%
2020 FY	-13.68 Thousand CAD	-105.2%
2020 Q4	-6741.00 CAD	0.0%
2020 Q2	- CAD	0.0%
2020 Q3	- CAD	0.0%
2020 Q1	- CAD	0.0%
2019 Q3	263.28 Thousand CAD	0.0%
2019 Q4	- CAD	-100.0%
2019 FY	263.28 Thousand CAD	0.0%
2019 Q1	- CAD	0.0%
2019 Q2	- CAD	0.0%
2018 FY	- CAD	0.0%
2018 Q4	- CAD	0.0%
2018 Q3	- CAD	0.0%
2018 Q1	- CAD	0.0%
2018 Q2	- CAD	0.0%
2017 Q3	- CAD	0.0%
2017 FY	- CAD	0.0%
2017 Q1	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 Q4	- CAD	0.0%
2016 Q1	- CAD	100.0%
2016 FY	- CAD	0.0%
2016 Q4	- CAD	0.0%
2016 Q3	- CAD	0.0%
2016 Q2	- CAD	0.0%
2015 FY	- CAD	0.0%
2015 Q1	- CAD	100.0%
2015 Q3	- CAD	-100.0%
2015 Q4	-4410.00 CAD	0.0%
2015 Q2	4410.00 CAD	0.0%
2014 FY	- CAD	0.0%
2014 Q3	9200.00 CAD	0.0%
2014 Q4	-9200.00 CAD	-200.0%
2014 Q2	- CAD	0.0%
2014 Q1	- CAD	0.0%
2013 FY	- CAD	0.0%

Peer Gross Profit Comparison of BioMark Diagnostics Inc.

Name	Gross Profit	Gross Profit Difference
Izotropic Corporation	-59.07 Thousand CAD	376.302%
Sona Nanotech Inc.	-456.76 Thousand CAD	135.734%